Stocks and InvestingStocks and Investing
Fri, March 19, 2021
Thu, March 18, 2021
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021

Andrew Baum Maintained (ABBV) at Strong Buy with Increased Target to $125 on, Mar 12th, 2021


Published on 2024-10-27 15:56:09 - WOPRAI, Andrew Baum
  Print publication without navigation


Andrew Baum of Citigroup, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $105 to $125 on, Mar 12th, 2021.

Andrew has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $110 on, Friday, December 11th, 2020


These are the ratings of the 8 analyists that currently disagree with Andrew


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $140 on, Thursday, February 4th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $126 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $124 on, Friday, December 11th, 2020
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $120 on, Thursday, December 10th, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $120 on, Monday, November 30th, 2020
  • Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020